X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-30 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.47 | +23,836 | 214,349 | +13% | +$11,308 | |||||
| A | 2024-05-28 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.52 | +15,000 | 3,165,712 | 0% | +$7,775 | |||||
| AM | 2024-05-21 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.61 | +50,000 | 3,150,712 | +2% | +$30,475 | |||||
| AM | 2024-05-10 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.47 | +40,000 | 3,100,712 | +1% | +$18,865 | |||||
| A | 2024-05-07 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.37 | +66,300 | 3,060,712 | +2% | +$24,816 | |||||
| A | 2024-05-06 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.38 | +135,000 | 2,994,412 | +5% | +$50,666 | |||||
| A | 2024-04-19 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.52 | +15,000 | 2,859,412 | +1% | +$7,799 | |||||
| AM | 2024-04-17 | BCLI | Lebovits Chaim | Pres, CEO | P - Purchase | $0.54 | +245,072 | 2,844,412 | +9% | +$131,411 | |||||
2024-07-19 | BCLI | Dagher Ibrahim B. | Chief Medical Officer | S - Sale | $0.35 | -63,000 | 190,000 | -25% | -$22,069 | ||||||
2023-09-01 | BCLI | Lindborg Stacy | Co-CEO | P - Purchase | $1.77 | +11,500 | 181,500 | +7% | +$20,402 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |